000			02216 a2200661 4500
005			20250518003901.0
264		0	_c20190813
008			201908s 0 0 eng d
022			_a1941-3297
024	7		_a10.1161/CIRCHEARTFAILURE.118.005400 _2doi
040			_aNLM _beng _cNLM
100	1		_aDeVore, Adam D
245	0	0	_aPatient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States. _h[electronic resource]
260			_bCirculation. Heart failure _c09 2018
300			_ae005400 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmbulatory Care _xtrends
650	0	4	_aAminobutyrates _xadverse effects
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xadverse effects
650	0	4	_aBiphenyl Compounds
650	0	4	_aClinical Decision-Making
650	0	4	_aDrug Combinations
650	0	4	_aFemale
650	0	4	_aGuideline Adherence _xtrends
650	0	4	_aHeart Failure _xdiagnosis
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeprilysin _xantagonists & inhibitors
650	0	4	_aPatient Selection
650	0	4	_aPatients
650	0	4	_aPractice Guidelines as Topic
650	0	4	_aPractice Patterns, Physicians' _xstandards
650	0	4	_aProtease Inhibitors _xadverse effects
650	0	4	_aRegistries
650	0	4	_aSpecialization _xtrends
650	0	4	_aTetrazoles _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
650	0	4	_aValsartan
700	1		_aHill, C Larry
700	1		_aThomas, Laine
700	1		_aSharma, Puza P
700	1		_aAlbert, Nancy M
700	1		_aButler, Javed
700	1		_aPatterson, J Herbert
700	1		_aSpertus, John A
700	1		_aWilliams, Fredonia B
700	1		_aDuffy, Carol I
700	1		_aMcCague, Kevin
700	1		_aHernandez, Adrian F
700	1		_aFonarow, Gregg C
773	0		_tCirculation. Heart failure _gvol. 11 _gno. 9 _gp. e005400
856	4	0	_uhttps://doi.org/10.1161/CIRCHEARTFAILURE.118.005400 _zAvailable from publisher's website
999			_c28971747 _d28971747